Clinical effects and tolerability of high-dose, high-frequency recombinant interferon beta-1a in patients with multiple sclerosis: maximizing therapy through long-term adherence.

Source:http://linkedlifedata.com/resource/pubmed/id/20218924

Download in:

View as

General Info

PMID
20218924